<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The findings of morphologically dysplastic features in hematopoietic cells in de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> has been known as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with trilineage <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>/TMDS) </plain></SENT>
<SENT sid="1" pm="."><plain>We analyzed the clinical data and treatment outcomes of 230 de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients treated with the Japan Adult <z:hpo ids='HP_0001909'>Leukemia</z:hpo> Study Group <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-87 protocol </plain></SENT>
<SENT sid="2" pm="."><plain>Forty (17%) patients had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>/TMDS </plain></SENT>
<SENT sid="3" pm="."><plain>It was detected in 21% to 34% of patients with M2, M4 and M6, and never seen in patients with M3 and M5 </plain></SENT>
<SENT sid="4" pm="."><plain>The median age was 48.5 years in the TMDS group and was 48 years in the patients without TMDS, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Platelet count was higher in the TMDS group than that in the TMDS </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>/TMDS was also characterized by fewer blasts in the bone marrow </plain></SENT>
<SENT sid="7" pm="."><plain>The complete remission (CR) rate was 63% and 81% in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients with and without TMDS, respectively; these rates being significantly different (p = 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>The predicted 5-year survival rate of the 40 patients with TMDS was significantly worse than that of the 190 patients without TMDS (9% vs 33%, p = 0.0005) </plain></SENT>
<SENT sid="9" pm="."><plain>The multivariate analysis revealed that the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>/TMDS was an unfavorable factor in the achievement of CR and in the prediction of longer survival </plain></SENT>
</text></document>